Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2026-01-06 @ 2:22 PM
Study NCT ID:
NCT06292858
Status:
RECRUITING
Last Update Posted:
2024-03-05
First Post:
2024-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors
Sponsor:
Beijng Immunoah Pharma Tech Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-24
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-08
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-20
First Submit QC Date:
None
Study First Post Date:
2024-03-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-27
Last Update Post Date:
2024-03-05
Last Update Post Date Type:
ACTUAL